and advisory/consultancy fees from Akero, Altimmune, Axcella Health, Becton Dickenson, Boehringer Ingelheim, Carmot Therapeutics, Echosens, 89bio, Eli Lilly & Company, Gilead, Intercept, Metacrine, Merck, Novo Nordisk, Pfizer and Sanofi
Emerging role of GLP-1 agonists in obesity: a comprehensive review of randomised controlled trials
Before founding his own firm, he was a partner at the New York office of Loeb & Loeb and Of Counsel at Thelen Reid Brown Raysman & Steiner
While further research is required to translate these preclinical findings into clinical practice, the identification of the GLP-1R/PPARG/ACSL1 pathway provides a clear roadmap for future investigations into the intersection of metabolic drugs and cancer immunotherapy in the future.
injections For people who have no preference between tablets and subcutaneous injections, the decision might come down to price